Clinical Trials
3
Active:0
Completed:0
Trial Phases
2 Phases
Phase 1:2
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (66.7%)Phase 2
1 (33.3%)A Safety and Efficacy Study of HPP404 on Weight Loss in Overweight or Obese Subjects
- First Posted Date
- 2012-02-29
- Last Posted Date
- 2015-09-04
- Lead Sponsor
- High Point Pharmaceuticals, LLC.
- Target Recruit Count
- 126
- Registration Number
- NCT01540864
- Locations
- 🇺🇸
Site 11, Augusta, Georgia, United States
🇺🇸Site 3, Valparaiso, Indiana, United States
🇺🇸Site 12, Louisville, Kentucky, United States
Safety Study of HPP593 in Subjects During and After Limb Immobilization
- First Posted Date
- 2012-02-02
- Last Posted Date
- 2014-07-15
- Lead Sponsor
- High Point Pharmaceuticals, LLC.
- Target Recruit Count
- 24
- Registration Number
- NCT01524406
- Locations
- 🇺🇸
Washington University School of Medicine Division of Geriatrics and Nutritional Studies, St. Louis, Missouri, United States
Safety Study of HPP854 in Subjects With Mild Cognitive Impairment or a Diagnosis of Mild Alzheimer's Disease
Phase 1
Terminated
- Conditions
- Mild Alzheimer's DiseaseMild Cognitive Impairment
- Interventions
- Drug: Placebo
- First Posted Date
- 2011-11-30
- Last Posted Date
- 2012-08-30
- Lead Sponsor
- High Point Pharmaceuticals, LLC.
- Target Recruit Count
- 7
- Registration Number
- NCT01482013
- Locations
- 🇺🇸
Elite Research Institute, Miami, Florida, United States
🇺🇸Duke Clinical Research Unit, Durham, North Carolina, United States
🇺🇸High Point Clinical Trials Center, High Point, North Carolina, United States
News
No news found